Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for Descriptive Characteristics of NOTCH1-Mutated Mantle Cell Lymphoma

MCL - 814

Descriptive Characteristics of NOTCH1-Mutated Mantle Cell Lymphoma

Ayda Soltanian

Poster Presenter: Ayda Soltanian

Thumbnail for Temporal Trends and Demographic Disparities in Mortality From Multiple Myeloma and Leukemia With Coexisting Coagulation and Hemorrhagic Disorders in the United States, 1999-2024: A CDC WONDER Multiple-Cause Mortality Analysis

MM - 815

Temporal Trends and Demographic Disparities in Mortality From Multiple Myeloma and Leukemia With Coexisting Coagulation and Hemorrhagic Disorders in the United States, 1999-2024: A CDC WONDER Multiple-Cause Mortality Analysis

Madho Mal

Poster Presenter: Madho Mal

Thumbnail for Racial Differences in Risk and Latency of Secondary Hematologic Malignancies Following Multiple Myeloma

MM - 816

Racial Differences in Risk and Latency of Secondary Hematologic Malignancies Following Multiple Myeloma

Damilola Ologbe

Poster Presenter: Damilola Ologbe

Thumbnail for Multilineage Hematologic Improvement in Lower-Risk Myelodysplastic Syndromes: Clinical Significance of Platelet and Neutrophil Recovery With Ofirnoflast, a Potent Allosteric Inhibitor of NEK7/NLRP3 Assembly

MDS - 819

Multilineage Hematologic Improvement in Lower-Risk Myelodysplastic Syndromes: Clinical Significance of Platelet and Neutrophil Recovery With Ofirnoflast, a Potent Allosteric Inhibitor of NEK7/NLRP3 Assembly

Jeremiah Bearss

Poster Presenter: Jeremiah Bearss

Thumbnail for Genomic Landscape of Primary Thyroid Lymphoma (Ptl): CD79B/MYD88 Alterations and Implications for Polatuzumab-Based Therapy

ABCL - 820

Genomic Landscape of Primary Thyroid Lymphoma (Ptl): CD79B/MYD88 Alterations and Implications for Polatuzumab-Based Therapy

Mehak Khetarpal

Poster Presenter: Mehak Khetarpal

Thumbnail for Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

MPN - 821

Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

Elmir Israfilov

Poster Presenter: Elmir Israfilov

Thumbnail for Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

CLL - 823

Venetoclax Initiation, Monitoring, and Interventions After Acalabrutinib Lead-In for Chronic Lymphocytic Leukemia

Emily Lee

Poster Presenter: Emily Lee

Thumbnail for Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

MDS - 824

Elritercept vs epoetin alfa in erythropoiesis-stimulating agent (ESA)-naοve adults with lower-risk myelodysplastic syndromes (MDS) and transfusion-dependent anemia: The ELRiSE MDS phase 3 study

Valeria Santini

Poster Presenter: Valeria Santini

Thumbnail for Mortality Trends in Lymphoid and Hematopoietic Malignancies With Circulatory-System Disease Involvement in the United States, 1999-2024

HL - 825

Mortality Trends in Lymphoid and Hematopoietic Malignancies With Circulatory-System Disease Involvement in the United States, 1999-2024

Madho Mal

Poster Presenter: Madho Mal

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.